PT3692039T - Enantiómeros de tiazóis substituídos como compostos antivirais - Google Patents
Enantiómeros de tiazóis substituídos como compostos antiviraisInfo
- Publication number
- PT3692039T PT3692039T PT187796966T PT18779696T PT3692039T PT 3692039 T PT3692039 T PT 3692039T PT 187796966 T PT187796966 T PT 187796966T PT 18779696 T PT18779696 T PT 18779696T PT 3692039 T PT3692039 T PT 3692039T
- Authority
- PT
- Portugal
- Prior art keywords
- enantiomers
- antiviral compounds
- substituted thiazoles
- thiazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17195047 | 2017-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3692039T true PT3692039T (pt) | 2023-03-07 |
Family
ID=60022026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT187796966T PT3692039T (pt) | 2017-10-05 | 2018-10-04 | Enantiómeros de tiazóis substituídos como compostos antivirais |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US11278534B2 (pt) |
| EP (2) | EP3692039B1 (pt) |
| JP (1) | JP7215689B2 (pt) |
| KR (1) | KR20200066619A (pt) |
| CN (1) | CN111433203B (pt) |
| AR (1) | AR113344A1 (pt) |
| AU (1) | AU2018344471B2 (pt) |
| BR (1) | BR112020006710A2 (pt) |
| CA (1) | CA3077397A1 (pt) |
| CL (1) | CL2020000869A1 (pt) |
| CR (1) | CR20200154A (pt) |
| DK (1) | DK3692039T3 (pt) |
| EA (1) | EA202090620A1 (pt) |
| EC (1) | ECSP20021132A (pt) |
| ES (1) | ES2939652T3 (pt) |
| FI (1) | FI3692039T3 (pt) |
| HR (1) | HRP20230158T1 (pt) |
| HU (1) | HUE061307T2 (pt) |
| IL (1) | IL273681A (pt) |
| JO (1) | JOP20200110A1 (pt) |
| LT (1) | LT3692039T (pt) |
| MA (1) | MA50609B1 (pt) |
| MD (1) | MD3692039T2 (pt) |
| MX (1) | MX2020003369A (pt) |
| NI (1) | NI202000025A (pt) |
| PH (1) | PH12020550132A1 (pt) |
| PL (1) | PL3692039T3 (pt) |
| PT (1) | PT3692039T (pt) |
| RS (1) | RS64000B1 (pt) |
| SG (1) | SG11202002420SA (pt) |
| SI (1) | SI3692039T1 (pt) |
| TW (1) | TWI706941B (pt) |
| UA (1) | UA126163C2 (pt) |
| UY (1) | UY37917A (pt) |
| WO (1) | WO2019068817A1 (pt) |
| ZA (1) | ZA202002150B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3692039T3 (fi) * | 2017-10-05 | 2023-03-23 | Innovative Molecules Gmbh | Substituoitujen tiatsolien enantiomeerejä virusten vastaisina yhdisteinä |
| US11760701B2 (en) | 2018-02-27 | 2023-09-19 | The Research Foundation For The State University Of New Yrok | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same |
| TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
| WO2022090409A1 (en) | 2020-10-29 | 2022-05-05 | Innovative Molecules Gmbh | Deuterated aminothiazole compounds as antiviral compounds |
| WO2023135303A1 (en) | 2022-01-17 | 2023-07-20 | Innovative Molecules Gmbh | Solid crystalline forms of helicase-primase inhibitors and process of preparation thereof |
| WO2024047508A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Pharmaceutical compositions for herpes virus |
| WO2024049760A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Cyclic urea thiazolyl compounds for treatment of hsv |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2075560A5 (pt) | 1970-01-16 | 1971-10-08 | Shell Int Research | |
| CZ207298A3 (cs) | 1995-12-29 | 1998-11-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Fenylthiazolové deriváty, způsob výroby a farmaceutický prostředek |
| US6040321A (en) * | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| WO1999042455A1 (en) | 1998-02-19 | 1999-08-26 | Tularik Inc. | Antiviral agents |
| EP1064273B1 (en) | 1998-03-19 | 2002-12-18 | PHARMACIA & UPJOHN COMPANY | 1,3,4-thiadiazoles useful for the treatment of cmv infections |
| DE50008597D1 (de) | 1999-03-08 | 2004-12-16 | Bayer Healthcare Ag | Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel |
| DE19959958A1 (de) | 1999-12-13 | 2001-08-30 | Bayer Ag | Thiazolylharnstoff-Derivate |
| DE19927415A1 (de) | 1999-06-16 | 2000-12-21 | Bayer Ag | Indolinylharnstoffderivate |
| DE10039265A1 (de) | 2000-08-11 | 2002-02-21 | Bayer Ag | Thiazolylamid-Derivate |
| DOP2000000109A (es) | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
| AU2000259734A1 (en) | 2000-06-15 | 2001-12-24 | Gerald Kleymann | Method for identifying compounds with anti-herpes activity |
| DE10038022A1 (de) | 2000-08-04 | 2002-02-14 | Bayer Ag | Inverse Thiazolylamid-Derivate |
| DE10044358A1 (de) | 2000-09-07 | 2002-03-21 | Bayer Ag | Thiazolylcarbonylheterocyclyl-Derivate |
| DE10044353A1 (de) | 2000-09-07 | 2002-04-04 | Bayer Ag | Unkompetitive Inhibitoren der Helikase-Primase |
| DE10044328A1 (de) | 2000-09-07 | 2002-03-21 | Bayer Ag | Thiazolylcarbonyl-Derivate |
| DE10129715A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Thiazolylamide |
| DE10129714A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Topische Anwendung von Thiazolylamiden |
| DE10129716A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
| DE10129717A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
| DE10131128A1 (de) | 2001-06-28 | 2003-01-16 | Bayer Ag | Sekundäre Sulfonamide |
| DE10210319A1 (de) | 2002-03-08 | 2003-09-18 | Bayer Ag | Thiazolylcarbonyl-Derivate |
| DE10235967B4 (de) | 2002-08-06 | 2005-09-08 | Bayer Healthcare Ag | Methode zum Identifizieren von Substanzen mit antimikrobieller Wirkung |
| DE10300109A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Methode zur Inhibition der Replikation von Herpesviren |
| BRPI0507278A (pt) | 2004-01-30 | 2007-06-26 | Vertex Pharma | moduladores dos transportadores do cassete de ligação ao atp |
| DE102005014248A1 (de) | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
| WO2008067839A1 (en) | 2006-12-08 | 2008-06-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Dry electrode cap for electro-encephalography |
| DE102010046720A1 (de) | 2010-09-23 | 2012-03-29 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur Herstellung von pan-CDK-Inhibitoren der Formel (l), sowie Intermediate der Herstellung |
| WO2012061190A1 (en) | 2010-11-01 | 2012-05-10 | Romark Laboratories L.C. | Alkylsulfinyl-substituted thiazolide compounds |
| TWI555737B (zh) | 2011-05-24 | 2016-11-01 | 拜耳知識產權公司 | 含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺 |
| EP2573086A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| TWI706940B (zh) * | 2016-04-06 | 2020-10-11 | 德商創新分子有限責任公司 | 新穎之抗病毒化合物 |
| PL3544976T3 (pl) | 2016-11-28 | 2021-11-02 | Aicuris Gmbh & Co. Kg | Hemihydrat wolnej zasady n-[5-(aminosulfonylo)-4-metylo-1,3-tiazol-2-ilo]-n-metylo-2-[4-(2-pirydynylo)fenylo]acetamidu, sposoby jego wytwarzania i zastosowania |
| CN117186084A (zh) | 2016-11-28 | 2023-12-08 | 艾库里斯有限及两合公司 | 普瑞利韦磺酸盐、其药物制剂、制造方法及治疗疱疹病毒的用途 |
| TW201825095A (zh) | 2016-11-28 | 2018-07-16 | 德商艾庫里斯抗感染治療有限公司 | 包含n-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之局部醫藥調配物 |
| EP3566749A4 (en) | 2017-01-09 | 2020-09-23 | Medshine Discovery Inc. | THIAZOLE DERIVATIVE AND USES OF IT |
| FI3692039T3 (fi) * | 2017-10-05 | 2023-03-23 | Innovative Molecules Gmbh | Substituoitujen tiatsolien enantiomeerejä virusten vastaisina yhdisteinä |
-
2018
- 2018-10-04 FI FIEP18779696.6T patent/FI3692039T3/fi active
- 2018-10-04 SI SI201830861T patent/SI3692039T1/sl unknown
- 2018-10-04 AU AU2018344471A patent/AU2018344471B2/en active Active
- 2018-10-04 ES ES18779696T patent/ES2939652T3/es active Active
- 2018-10-04 PT PT187796966T patent/PT3692039T/pt unknown
- 2018-10-04 WO PCT/EP2018/077022 patent/WO2019068817A1/en active Application Filing
- 2018-10-04 EA EA202090620A patent/EA202090620A1/ru unknown
- 2018-10-04 JO JOP/2020/0110A patent/JOP20200110A1/ar unknown
- 2018-10-04 PL PL18779696.6T patent/PL3692039T3/pl unknown
- 2018-10-04 MA MA50609A patent/MA50609B1/fr unknown
- 2018-10-04 LT LTEPPCT/EP2018/077022T patent/LT3692039T/lt unknown
- 2018-10-04 MX MX2020003369A patent/MX2020003369A/es unknown
- 2018-10-04 UA UAA202002635A patent/UA126163C2/uk unknown
- 2018-10-04 UY UY0001037917A patent/UY37917A/es unknown
- 2018-10-04 US US16/753,814 patent/US11278534B2/en active Active
- 2018-10-04 CN CN201880065255.2A patent/CN111433203B/zh active Active
- 2018-10-04 KR KR1020207009294A patent/KR20200066619A/ko not_active Application Discontinuation
- 2018-10-04 BR BR112020006710A patent/BR112020006710A2/pt unknown
- 2018-10-04 JP JP2020519403A patent/JP7215689B2/ja active Active
- 2018-10-04 CA CA3077397A patent/CA3077397A1/en active Pending
- 2018-10-04 RS RS20230156A patent/RS64000B1/sr unknown
- 2018-10-04 SG SG11202002420SA patent/SG11202002420SA/en unknown
- 2018-10-04 EP EP18779696.6A patent/EP3692039B1/en active Active
- 2018-10-04 AR ARP180102864A patent/AR113344A1/es unknown
- 2018-10-04 EP EP22213253.2A patent/EP4209491A1/en active Pending
- 2018-10-04 MD MDE20200816T patent/MD3692039T2/ro unknown
- 2018-10-04 CR CR20200154A patent/CR20200154A/es unknown
- 2018-10-04 HR HRP20230158TT patent/HRP20230158T1/hr unknown
- 2018-10-04 DK DK18779696.6T patent/DK3692039T3/da active
- 2018-10-04 TW TW107135101A patent/TWI706941B/zh active
- 2018-10-04 HU HUE18779696A patent/HUE061307T2/hu unknown
-
2020
- 2020-03-25 PH PH12020550132A patent/PH12020550132A1/en unknown
- 2020-03-29 IL IL273681A patent/IL273681A/en unknown
- 2020-04-01 NI NI202000025A patent/NI202000025A/es unknown
- 2020-04-01 CL CL2020000869A patent/CL2020000869A1/es unknown
- 2020-04-03 EC ECSENADI202021132A patent/ECSP20021132A/es unknown
- 2020-05-04 ZA ZA2020/02150A patent/ZA202002150B/en unknown
-
2022
- 2022-01-21 US US17/581,166 patent/US20220152008A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291099A (en) | Aminothiazole compounds as c–kit inhibitors | |
| IL255817B (en) | Synthesis of heterocyclic compounds | |
| IL263825A (en) | Heterocyclic compounds as immunomodulators | |
| IL272888B1 (en) | Uses of piperidinyl-indole derivatives | |
| EP3929197C0 (en) | INTERMEDIATES FOR THE SYNTHESIS OF MICROBIOCIDE HETEROBICYCLIC DERIVATIVES | |
| ZA202002150B (en) | Enantiomers of substituted thiazoles as antiviral compounds | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| IL263050B (en) | History of Subtirum | |
| EP3548487A4 (en) | POLYMORPHE SHAPE OF SEPIAPTERIN | |
| IL249041A0 (en) | Solid forms of an antiviral compound | |
| EP3372601A4 (en) | NEW HETEROCYCLIC BICYCLIC COMPOUND | |
| IL272697A (en) | A polymorphic form of TG02 | |
| IL263673A (en) | Solid state forms of spiro-oxindole compounds | |
| EP3339287A4 (en) | NEW TYPE OF ANTIVIRAL COMPOUND | |
| EP3334703A4 (en) | SYNTHESIS OF ARYLIC COMPOUNDS | |
| HUE050745T2 (hu) | Kiegyenlítõ keverék alkalmazása | |
| GB201609314D0 (en) | Methods of forming compounds | |
| SI3606908T1 (sl) | Delitev racemičnih beta-aminosulfonskih spojin | |
| EP3446689A4 (en) | USE OF ISOTHIOCYANATE COMPOUNDS | |
| AU2015903284A0 (en) | Synthesis of aryl compounds |